2A,B, a static analysis revealed that both Ex-4 and GEP44 potentiated the insulin secretion rate (ISR) by 62% and 37%, respectively, over 20 mM glucose alone
Common gastrointestinal effects are the most frequently reported adverse reactions, with studies reporting variable rates of digestive symptoms: Diarrhoea and loose stools Abdominal cramping and discomfort Constipation (less common) Nausea and bloating These effects are typically dose-dependent and may improve with gradual dose escalation or taking berberine with meals
Leggio: That's a wonderful question
USP53, the gene responsible for PFIC7, was found to be related to hearing loss and hypocalcemia [51]
Furthermore, we did not assess body composition changes systematically over the course of GLP-1 RA treatment due to patients reluctance
Patients whose only complaint is weight and who have no secondary concerns about skin, hair, inflammation, or tissue quality are better served by optimizing their GLP-1 protocol, adding resistance training, and addressing nutrition rather than adding a peptide that doesnt directly address their primary goal
